Slimfast Fades as Dieters Turn to Weight Loss Drugs
Sales of SlimFast, the meal replacement shakes, have dropped in the US as people turn to new blockbuster
1970-01-01 08:00
European Stocks Lifted by Luxury as China Eases Travel Curbs
European stocks extended gains into a second session, as China’s decision to relax travel curbs offered a lift
1970-01-01 08:00
Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo Nordisk A/S said the supply of its blockbuster obesity medicine Wegovy will continue to be restricted in
1970-01-01 08:00
Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost
Novo Nordisk A/S has just reached another milestone in its meteoric rise: the market value of the Danish
1970-01-01 08:00
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo
1970-01-01 08:00
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the
1970-01-01 08:00
Russian warship damaged in Ukrainian attack on Novorossiysk naval base - sources
(Reuters) -A Russian warship was seriously damaged in an overnight Ukrainian naval drone attack on Russia's Black Sea navy base
1970-01-01 08:00
Dagestan profile
Provides an overview of Dagestan, including key facts about this Russian Caucasian republic.
1970-01-01 08:00
Novo Nordisk weight-loss drug Wegovy launched in Germany, first big EU market
By Ludwig Burger and Maggie Fick FRANKFURT Novo Nordisk has launched blockbuster weight-loss drug Wegovy in Germany, its
1970-01-01 08:00
"Last hope": Eager Germans are prepared to pay for weight-loss drug
By Ludwig Burger and Maggie Fick FRANKFURT/LONDON Frustrated after countless failed diet and exercise attempts, 41 year-old Jessica
1970-01-01 08:00
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and
1970-01-01 08:00
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
By Maggie Fick LONDON Soaring U.S. demand for Novo Nordisk's weight-loss drug has reduced the pressure from investors
1970-01-01 08:00